Sort
8,912 grants matching “sars cov 2”
Medical Mistrust as a Barrier to COVID-19 and HIV Services Among Transgender Women of Color
$404,611Dustin T Duncan · Columbia University Health Sciences · R01 · FY2022 · MD
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD - Microbiome Admin Suppl
$404,554Adam Peter Spira · Johns Hopkins University · R01 · FY2023 · AG
Medical Mistrust as a Barrier to COVID-19 and HIV Services Among Transgender Women of Color
$404,281Dustin T Duncan · Columbia University Health Sciences · R01 · FY2021 · MD
Biochemistry of SARS-CoV-2 Spike Protein and its Ocular Surface Membrane Receptor
$404,162T. Michael Redmond · National Eye Institute · ZIA · FY2023 · EY
Project 1 - A systems biology approach to identify early networks and signatures associated with mild and severe SARS-CoV-2 infections in vivo
$403,954Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Modeling the dynamics of disease elimination
$403,750Seth Blumberg · University Of California, San Francisco · R35 · FY2024 · GM
Modeling the dynamics of disease elimination
$403,750Seth Blumberg · University Of California, San Francisco · R35 · FY2025 · GM
Modeling the dynamics of disease elimination
$403,750Seth Blumberg · University Of California, San Francisco · R35 · FY2022 · GM
Modeling the dynamics of disease elimination
$403,750Seth Blumberg · University Of California, San Francisco · R35 · FY2023 · GM
Scientific Project 1: Malaria Immune Responses to Pre-erythrocytic Malaria Vaccination or Infection
$403,711Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2023 · AI
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
$403,465Ann C. Palmenberg · University Of Wisconsin-Madison · U19 · FY2021 · AI
A novel strategy for developing a SARS-CoV vaccine
$403,341Stanley Perlman · University Of Iowa · R56 · FY2009 · AI
Modeling viral entry and its inhibition using SARS-CoV
$403,250Graham Simmons · Vitalant · R01 · FY2008 · AI
Modeling viral entry and its inhibition using SARS-CoV
$403,250Graham Simmons · Vitalant · R01 · FY2009 · AI
Human epidemiology and response to SARS-CoV-2 (HEROS)
$403,137Daniel J Jackson · University Of Wisconsin-Madison · UM1 · FY2021 · AI
Core B: Organoid Core
$403,095Calvin J Kuo · Stanford University · U19 · FY2025 · AI
System Immunogenetics of Innate Immune and Inflammatory Responses to West Nile V
$402,956Michael J Gale · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
CORALE-SeroNet Project 2
$402,829Noah M Merin · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico
$402,632Charles Wood · Lsu Health Sciences Center · R01 · FY2024 · DA
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · DK
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
$402,500Roger Keith Reeves · Duke University · R01 · FY2023 · DK
Understanding the interplay between local viral infection and local inflammation in COVID-19 kidney injury
$402,500Maria Blasi · Duke University · R01 · FY2023 · DK
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · DK
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · DK
Understanding the interplay between local viral infection and local inflammation in COVID-19 kidney injury
$402,500Maria Blasi · Duke University · R01 · FY2021 · DK